Release Date: 14/07/21 10:42 Summary: Chairman's Address to Shareholders Price Sensitive: No Download Document 653.6KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%